Louis Chen

Stock Analyst at Cantor Fitzgerald

(n/a)
# 4,826
Out of 4,829 analysts
11
Total ratings
9.09%
Success rate
-63.32%
Average return
Main Sectors:

Stocks Rated by Louis Chen

Perspective Therapeutics
Sep 10, 2024
Reiterates: Overweight
Price Target: n/a
Current: $2.51
Upside: -
Theratechnologies
Jul 13, 2023
Reiterates: Overweight
Price Target: $36
Current: $2.63
Upside: +1,271.43%
Vaxcyte
Feb 24, 2022
Reiterates: Overweight
Price Target: $55
Current: $31.59
Upside: +74.11%